[Association of VM26, mitomycine C, methotrexate in patients with metastatic carcinoma of the breast resistant to a combination of 4 drugs including adriamycin. Results of a type II study (autohr's transl)].
D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D008937:Mitomycins / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*
D008937:Mitomycins; D004317:Doxorubicin; D013713:Teniposide; D011034:Podophyllotoxin; D008727:Methotrexate
Association de VM 26, mitomycine C, méthotrexate chez des malades ayant des cancers du sein métastasés résistants à une combinaison de 4 drogues comportant l'adriamycine. Résultats d'un essai de type II.